Leukemia, Prolymphocytic
2 clinical trials · Condition
◉ Watch Leukemia, Prolymphocytic
| Record | Firm | Date |
|---|---|---|
| Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) (NCT01419691) | University of Kansas Medical Center | 2011-09-01 |
| Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL (NCT00546793) | Gilead Sciences | 2008-01-01 |
Track Leukemia, Prolymphocytic automatically
Every clearance here is in the API, with alerts when new ones post.